Shibani Sircar Kurian on what to buy in metal and pharma
“We believe that within the pharma sector the domestic formulations business is showing double digit growth and within that, there are a few companies which are growing at a faster pace and therefore this is a segment which we continue to remain positive on and here valuations seem to be fairly attractive.”
